Log in to save to my catalogue

Sustained unresponsiveness in peanut oral immunotherapy

Sustained unresponsiveness in peanut oral immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2290953989

Sustained unresponsiveness in peanut oral immunotherapy

About this item

Full title

Sustained unresponsiveness in peanut oral immunotherapy

Author / Creator

Publisher

London: Elsevier Ltd

Journal title

The Lancet (British edition), 2019-10, Vol.394 (10207), p.1392-1393

Language

English

Formats

Publication information

Publisher

London: Elsevier Ltd

More information

Scope and Contents

Contents

Peanut allergy is a potentially life-threatening disease with substantial impact on the quality of life of patients and carers.1 Many initiatives are underway to develop treatment alternatives for strict peanut avoidance. In real-life settings, risk factors such as exercise, viral infections, or poor treatment adherence might be less consciously mo...

Alternative Titles

Full title

Sustained unresponsiveness in peanut oral immunotherapy

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2290953989

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2290953989

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(19)31816-1

How to access this item